A fast and sensitive method for quantifying lumefantrine and desbutyl-lumefantrine using LC-MS/MS.
Summary
A new LC-MS/MS method accurately quantifies lumefantrine (LUM) and desbutyl-lumefantrine (DBL) in human plasma. This high-throughput assay is crucial for monitoring malaria treatment efficacy in children.
Area of Science:
- Pharmacokinetics and Drug Metabolism
- Analytical Chemistry
- Clinical Diagnostics
Background:
- Accurate quantification of antimalarial drugs like lumefantrine (LUM) and its metabolites is essential for assessing treatment efficacy and understanding drug disposition.
- Existing methods may lack the sensitivity, throughput, or sample volume efficiency required for routine clinical monitoring, particularly in pediatric populations.
Purpose of the Study:
- To develop and validate a sensitive, rapid, and robust liquid chromatography-tandem mass spectrometry (LC-MS/MS) method for quantifying LUM and its primary metabolite, desbutyl-lumefantrine (DBL), in human plasma.
- To establish a high-throughput analytical method suitable for pharmacokinetic studies and therapeutic drug monitoring in children.
Main Methods:
- Development of a protein precipitation method using acetonitrile with deuterated internal standards (LUM-d18, DBL-d9).
- Utilized a Hypersil Gold C18 column with a short run time (2.2 min) and a gradient elution involving formic acid in water and methanol.
- Quantification performed using positive electrospray ionization (ESI+) and selected reaction monitoring (SRM) on a tandem mass spectrometer.
Main Results:
- The method demonstrated excellent sensitivity with measuring ranges of 21-529 ng/mL for LUM and 1.9-47 ng/mL for DBL.
- High precision (within 10% CV) and accuracy (within ±10%) were achieved for both analytes across all tested levels.
- The method requires a small plasma volume (100 μL) and exhibits good sample stability, allowing for high-throughput analysis.
Conclusions:
- The validated LC-MS/MS method provides a sensitive, accurate, and efficient means for quantifying LUM and DBL in human plasma.
- This method is suitable for therapeutic drug monitoring and pharmacokinetic studies, particularly in pediatric malaria patients treated with artemether-lumefantrine.
- The assay's high throughput and minimal sample requirement facilitate its application in clinical settings and research.
Keywords:
Desbutyl-lumefantrineLiquid chromatographyLumefantrineMalariaPlasmaPlasmodium falciparumSensivityTandem mass spectrometryMore Related Videos
09:58Spatial Quantification of Drugs in Pulmonary Tuberculosis Lesions by Laser Capture Microdissection Liquid Chromatography Mass Spectrometry LCM-LC/MS
Published on: April 18, 2018
9.7K
10:13Author Spotlight: An Efficient Methodology to Confidently Differentiate and Characterize Fentanyl Analogs
Published on: November 8, 2024
3.0K
